| COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study LYW Lee, JB Cazier, T Starkey, SEW Briggs, R Arnold, V Bisht, S Booth, ... The Lancet Oncology 21 (10), 1309-1316, 2020 | 667 | 2020 |
| Immunotherapy for cervical cancer: Research status and clinical potential JH Su, A Wu, E Scotney, B Ma, A Monie, CF Hung, TC Wu BioDrugs 24, 109-129, 2010 | 160 | 2010 |
| Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective … DJ Pinato, J Tabernero, M Bower, L Scotti, M Patel, E Colomba, S Dolly, ... The Lancet Oncology 22 (12), 1669-1680, 2021 | 135 | 2021 |
| Genome-wide plasma DNA methylation features of metastatic prostate cancer A Wu, P Cremaschi, D Wetterskog, V Conteduca, GM Franceschini, ... The Journal of clinical investigation 130 (4), 1991-2000, 2020 | 88 | 2020 |
| Outcomes of the SARS-CoV-2 omicron (B. 1.1. 529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre … DJ Pinato, D Ferrante, G Hanbury, M Bower, R Salazar, O Mirallas, ... The Lancet Oncology 23 (7), 865-875, 2022 | 77 | 2022 |
| Mortality among adults with cancer undergoing chemotherapy or immunotherapy and infected with COVID-19 C Várnai, C Palles, R Arnold, HM Curley, K Purshouse, VWT Cheng, ... JAMA network open 5 (2), e220130-e220130, 2022 | 66 | 2022 |
| Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges B Trujillo, A Wu, D Wetterskog, G Attard British Journal of Cancer 127 (8), 1394-1402, 2022 | 60 | 2022 |
| Cancer history and systemic anti-cancer therapy independently predict COVID-19 mortality: a UK tertiary hospital experience CCT Sng, YNS Wong, A Wu, D Ottaviani, N Chopra, M Galazi, S Benafif, ... Frontiers in oncology 10, 595804, 2020 | 25 | 2020 |
| Plasma DNA analysis in prostate cancer: opportunities for improving clinical management A Wu, G Attard Clinical Chemistry 65 (1), 100-107, 2019 | 19 | 2019 |
| Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective G Soosaipillai, A Wu, GM Dettorre, N Diamantis, J Chester, C Moss, ... Therapeutic Advances in Medical Oncology 13, 17588359211042224, 2021 | 6 | 2021 |
| Systemic anti-cancer therapy and metastatic cancer are independent mortality risk factors during two UK waves of the COVID-19 pandemic at university college london hospital YNS Wong, CCT Sng, D Ottaviani, G Patel, A Chowdhury, I Earnshaw, ... Cancers 13 (23), 6085, 2021 | 3 | 2021 |
| Accidentals of the DNA Symphony A Wu, G Attard Cancer Research 82 (21), 3880-3881, 2022 | 1 | 2022 |
| 1704P COVID-19 mortality in patients receiving anti-cancer therapy in a UK national cancer centre A Wu, CCT Sng, S Benafif, N Chopra, M Galazi, AJX Lee, D Ottaviani, ... Annals of Oncology 31, S1004, 2020 | 1 | 2020 |
| Prostate cancer detection methods A Wu, G Attard, P Cremaschi, D Wetterskog US Patent App. 17/770,974, 2022 | | 2022 |
| 1575P Systemic anti-cancer therapy and metastatic cancer are independent mortality risk factors during two UK waves of the COVID-19 pandemic at University College London Hospital A Sinclair, I Earnshaw, A Chowdhury, G Patel, N Chopra, E Merry, ... Annals of Oncology 32, S1138, 2021 | | 2021 |
| 1734P Do cancer patients really do worse? A study in a UK tertiary hospital within a COVID-19 epicentre CCT Sng, A Wu, YNS Wong, GB Soosaipillai, D Ottaviani, AJX Lee, ... Annals of Oncology 31, S1015, 2020 | | 2020 |
| Circulating cell-free DNA methylation analysis of metastatic prostate cancer A Wu Institute of Cancer Research (University Of London), 2020 | | 2020 |
| Pan-genome cfDNA methylation analysis of metastatic prostate cancer A Wu, P Cremaschi, D Wetterskog, V Conteduca, GM Franceschini, ... Annals of Oncology 30, vii1, 2019 | | 2019 |
| Immunotherapie van HPV-gerelateerde tumoren van cervix en vulva JH Su, A Wu, E Scotney, B Ma, A Monie, CF Hung, TC Wu BioDrugs 24 (2), 109-29, 2010 | | 2010 |
| Combination of apigenin treatment with therapeutic HPV DNA vaccination generates enhanced therapeutic antitumor effects. CCM Chuang ChiMu, A Monie, A Wu, HCF Hung ChienFu | | 2009 |